INNOVUS PHARMACEUTICALS, INC.
INNOVUS PHARMACEUTICALS, INC. (INNV): 3 pipeline candidates. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
N/A
D/E -5.77 · 0% dilution
Lead: Preclinical
3 candidates
N/A
N/A
A transparent, data-derived signal for INNOVUS PHARMACEUTICALS, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$1.3B
Cash
—
Quarterly Burn
$514K
Runway
—
Revenue
$5.8M
Pipeline (3 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
101
Total value held
$78.7M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 1,754,272 | $14.1M |
| blackrock, inc. | 1,248,091 | $10.0M |
| coliseum capital management, llc | 1,114,809 | $8.9M |
| geode capital management, llc | 573,417 | $4.6M |
| state street corp | 431,426 | $3.5M |
| arrowstreet capital, limited partnership | 417,538 | $3.3M |
| renaissance technologies llc | 370,817 | $3.0M |
| o'shaughnessy asset management, llc | 272,540 | $2.2M |
| northern trust corp | 267,137 | $2.1M |
| ritholtz wealth management | 248,072 | $2.0M |
Showing top 10 of 101 institutional holders of INNOVUS PHARMACEUTICALS, INC.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in INNOVUS PHARMACEUTICALS, INC.'s pipeline?
INNOVUS PHARMACEUTICALS, INC. (INNV) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is INNOVUS PHARMACEUTICALS, INC.'s lead drug candidate?
INNOVUS PHARMACEUTICALS, INC.'s most advanced tracked candidate is musclin (Preclinical) for increase muscle mass, endurance and activity.
What is INNOVUS PHARMACEUTICALS, INC.'s market capitalization?
INNOVUS PHARMACEUTICALS, INC.'s market capitalization is approximately $1.3B.
Who is the CEO of INNOVUS PHARMACEUTICALS, INC.?
Mr. Patrick Blair is the chief executive officer of INNOVUS PHARMACEUTICALS, INC. (INNV).
Get the full picture on INNOVUS PHARMACEUTICALS, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.